Glutathione and the response of malignant cells to chemotherapy

Pamela R. Kearns, Andrew G. Hall*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)


In the past, the role of glutathione (GSH) in the production of drug resistance was assumed to be limited to electrophilic agents such as the bifunctional alkylating agents and cisplatin. Recently, however, evidence has emerged that links GSH homeostasis with regulation of the multidrug-resistance-related protein and the control of apoptotic cell death. These findings open up new avenues for the discovery of drugs that augment anticancer agents already in use or that have cytotoxic potential in their own right.

Original languageEnglish
Pages (from-to)113-121
Number of pages9
JournalDrug Discovery Today
Issue number3
Publication statusPublished - 1 Mar 1998

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology


Dive into the research topics of 'Glutathione and the response of malignant cells to chemotherapy'. Together they form a unique fingerprint.

Cite this